Toggle light / dark theme

Critical infrastructure, entertainment, finance, healthcare, telecoms, among recent targets of the Lazarus Group, aka Hidden Cobra.

On the eve of a historic summit with its rival neighbor South Korea and possible subsequent talks with the US President Donald Trump in the coming weeks, North Korea continues full-steam ahead in its mission to gather intelligence and generate income for the regime via its notorious nation-state hacking machine.

North Korea’s pervasive Lazarus Group, aka Hidden Cobra, was recently discovered ramping up a global cyber espionage campaign dubbed Operation GhostSecret, stealing information from organizations in the critical infrastructure, entertainment, finance, healthcare, and telecommunications sectors. Researchers from McAfee unearthed the wave of attacks, which they say first started with targeted hacks of banks in Turkey last month.

Read more

Cloud-based, AI-powered location technology is creating the highly accurate and always up-to-date maps that can revolutionize everything from autonomous cars to connected cities. To learn more about the application of data-enriched mapping to industries from retail to automotive, manufacturing, transportation and city planning, don’t miss this VB Live event!

Register here for free.

Location is at the heart of everything: it’s the nexus between a device or an individual and the environment they interact with, and it can become the foundation of a smarter society. Location data is powered by cloud capabilities: global maps, traffic information and hundreds of millions of connected devices brought together to create the most up-to-date maps and power the “The Location of Things.”

Read more

Tired of writing your own boring code for new software? Finally, there’s an AI that can do it for you.

BAYOU is an deep learning tool that basically works like a search engine for coding: tell it what sort of program you want to create with a couple of keywords, and it will spit out java code that will do what you’re looking for, based on its best guess.

The tool was developed by a team of computer scientists from Rice University who received funding both from the military and Google. In a study published earlier this month on the preprint server arXiv, they describe how they built BAYOU and what sorts of problems it can help programmers solve.

Read more

Peering billions of light-years back to when the Universe was just 10 percent of its current age, astronomers have spotted a colossal pile-up: 14 young, starbursting galaxies merging into one of the most massive structures in the Universe.

Using some of the most powerful telescopes in operation today, an international research team discovered the extremely dense concentration of hot galaxies careening towards each other.

Eventually the megamerger will form a cluster of galaxies, gravitationally bound by dark matter and ultimately smooshing together into one ginormous galaxy.

Read more

Taking the supplement, dilation of subjects’ arteries improved by 42 percent, making their blood vessels, at least by that measure, look like those of someone 15 to 20 years younger. An improvement of that magnitude, if sustained, is associated with about a 13 percent reduction in heart disease, Rossman said. The study also showed that the improvement in dilation was due to a reduction in oxidative stress.


Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.

The study, published this week in the American Heart Association journal Hypertension, adds to a growing body of evidence suggesting pharmaceutical-grade nutritional supplements, or nutraceuticals, could play an important role in preventing heart disease-the nation’s No. 1 killer. It also resurrects the notion that oral antioxidants, which have been broadly dismissed as ineffective in recent years, could reap measurable health benefits if properly targeted, the authors say.

“This is the first clinical trial to assess the impact of a mitochondrial-specific antioxidant on vascular function in humans,” said lead author Matthew Rossman, a postdoctoral researcher in the department of integrative physiology. “It suggests that therapies like this may hold real promise for reducing the risk of age-related cardiovascular disease.”